Study of an implant for vision loss from advanced AMD
Part of Eyes & vision clinical trials.
This trial tests a small telescope implant for people with advanced age-related macular degeneration (AMD) in both eyes. It aims to improve central vision in the eye where the implant is placed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 years or older.
- You have advanced AMD (geographic atrophy or scar) in both eyes.
- You had cataract surgery in both eyes at least 6 months ago.
- Your best corrected vision in both eyes is between 20/80 and 20/800.
- You still have useable side vision in the non-surgery eye.
- You can see at least 2 lines better on a vision chart with a special training device in the surgery eye.
- The depth of your eye's front chamber is at least 2.5 mm in both eyes.
- The cell count on the inside of your cornea is at least 1600 cells per mm² in both eyes.
- You are willing to take part in a training program after surgery to learn how to use the implant.
- You do not have active bleeding in the back of the eye, diabetic eye disease, certain other eye conditions, or have had a retinal detachment.
- You do not have a history of glaucoma or high eye pressure, and are not allergic to post-surgery medications.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to measure vision and take detailed eye images in people with age-related macular degeneration (AMD), a common eye condition affecting central vision. The goal is to develop better tools for future AMD treatment trials.
This trial compares two types of artificial lenses (standard and extended depth of focus) implanted during cataract surgery in people who also have an epiretinal membrane (a wrinkle on the eye's surface). It aims to find which lens provides better vision quality after surgery.
This study tests a device that is surgically implanted in the eye of people with late-stage age-related macular degeneration (AMD). It also uses vision training with a telescope-like tool to see if the treatment can improve day-to-day vision.
This post-approval study tests whether an implantable mini telescope can improve vision in people with advanced age-related macular degeneration that affects the center of vision. You may qualify if your vision loss matches a specific pattern and you can complete required eye training before and after surgery.
This trial tests a patch of retinal cells implanted under the retina to see if it can slow or stop vision loss from advanced dry AMD (geographic atrophy). It may help people whose central vision is already affected.
This trial is testing a new eye implant (TO-O-1007) to see if it's safe and helps slow vision loss from geographic atrophy, a late stage of dry age-related macular degeneration (AMD). The implant is placed inside the eye and releases medicine over time.
Hear when a new Age - Related Macular Degeneration (AMD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.